Sort
10,829 grants matching “car t”
INFLUENCE TRIAL: IMPROVING EVENT-FREE SURVIVAL BY OPTIMIZING FLUDARABINE EXPOSURE DURING LYMPHODEPLETION FOR CAR T CELL THERAPY
$4,029,612Sloan-Kettering Institute For Cancer Research · · FY2024 · Defense Health Agency
Mechanisms and biological consequences of the nuclear receptor CAR activation
$4,009,469Masahiko Negishi · National Institute Of Environmental Health Sciences · ZIA · FY2009 · ES
B7-H3-SPECIFIC CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL IMMUNOTHERAPY FOR METASTATIC TRIPLE-NEGATIVE BREAST CANCER (MTNBC)
$4,004,834The General Hospital Corporation · · FY2020 · Defense Health Agency
PIRE: Science of Design for Societal-Scale Cyber-Physical Systems
$4,000,000Janos Sztipanovits · Vanderbilt University · · FY2017 · O/D
Adult Leukemia Research Center
$3,990,002Frederick R Appelbaum · Fred Hutchinson Cancer Research Center · P01 · FY2020 · CA
Adult Leukemia Research Center
$3,990,001Frederick R Appelbaum · Fred Hutchinson Cancer Research Center · P01 · FY2018 · CA
RII Track-2 FEC: The Visual Experience Database: A Large-Scale Point-of-View Video Database for Vision Research
$3,974,003Michelle R Greene · Bates College · · FY2019 · O/D
Multispecific targeting incorporating cytokine receptor pathways in high risk pediatric acute leukemias to improve durability of adoptive cell therapy-induced remissions
$3,950,741Terry J. Fry · University Of Colorado Denver · U01 · FY2018 · CA
Adult Leukemia Research Center
$3,910,199Geoffrey Roger Hill · Fred Hutchinson Cancer Center · P01 · FY2022 · CA
Adult Leukemia Research Center
$3,870,300Frederick R Appelbaum · Fred Hutchinson Cancer Research Center · P01 · FY2019 · CA
Mechanisms and biological consequences of the nuclear receptor CAR activation
$3,844,356Masahiko Negishi · National Institute Of Environmental Health Sciences · ZIA · FY2010 · ES
C: Quantum-Enhanced Inertial Measurement Unit (QEIMU)
$3,834,658Zheshen Zhang · Regents Of The University Of Michigan - Ann Arbor · · FY2022 · TIP
Autologous chimeric antigen receptor engineered T cell immunotherapy for desensitization in patients awaiting kidney transplantation
$3,825,129Ali Naji · University Of Pennsylvania · U01 · FY2024 · AI
Adoptive cell therapy for malignant mesothelioma and other mesothelin expressing
$3,790,575Raffit Hassan · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Protein Trafficking In The Endosomal-Lysosomal System
$3,742,993Juan Bonifacino · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2012 · HD
Lipid and Lipoprotein Metabolism in Atherosclerosis
$3,670,549Alan M Fogelman · University Of California Los Angeles · P01 · FY2006 · HL
IGERT: Vision and Learning in Humans and Machines
$3,663,975Virginia De Sa · University Of California-San Diego · · FY2003 · EDU
Defining and overcoming intrinsic T cell dysfunction to enable pediatric immunotherapy
$3,651,996Stephan A Grupp · Children'S Hosp Of Philadelphia · U01 · FY2019 · CA
Immunoengineering Durable Control of HIV Replication
$3,643,653James L Riley · University Of Pennsylvania · P01 · FY2025 · AI
Lipid and Lipoprotein Metabolism in Atherosclerosis
$3,584,797University Of California Los Angeles · P01 · FY2005 · HL
Individualized HIV Curative Combination Strategy against Persistent HIV on ART
$3,568,644Luis J. Montaner · Wistar Institute · UM1 · FY2025 · AI
Northern California Comprehensive Sickle Cell Centers
$3,557,214Elliott P Vichinksy · Children'S Hospital & Res Ctr At Oakland · U54 · FY2007 · HL
Lipid and Lipoprotein Metabolism in Atherosclerosis
$3,512,187Alan M Fogelman · University Of California Los Angeles · P01 · FY2007 · HL
Collaborative Research: Expeditions in Computing: The Science of Deep Specification
$3,453,419Andrew W Appel · Princeton University · · FY2015 · CSE
Deciphering the efficacy of posttransplant cyclophosphamide in BMT
$3,453,330Christopher Kanakry · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA